Venus Concept Inc. (NASDAQ:VERO) Short Interest Down 13.5% in January

Venus Concept Inc. (NASDAQ:VERO) was the recipient of a large drop in short interest in January. As of January 15th, there was short interest totaling 172,610 shares, a drop of 13.5% from the December 31st total of 199,499 shares. Approximately 16.8% of the shares of the stock are sold short. Based on an average daily volume of 1,896,828 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 1,896,828 shares, the days-to-cover ratio is presently 0.1 days. Approximately 16.8% of the shares of the stock are sold short.

Venus Concept Stock Performance

Shares of Venus Concept stock opened at $1.40 on Tuesday. Venus Concept has a fifty-two week low of $1.16 and a fifty-two week high of $14.50. The company has a debt-to-equity ratio of 1.59, a current ratio of 0.90 and a quick ratio of 0.59. The firm has a market capitalization of $1.99 million, a P/E ratio of -0.03 and a beta of -0.04. The company’s 50 day moving average price is $2.00 and its two-hundred day moving average price is $2.19.

Venus Concept (NASDAQ:VERO) last announced its quarterly earnings results on Thursday, November 13th. The company reported ($12.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.61) by ($8.53). Venus Concept had a negative return on equity of 1,904.25% and a negative net margin of 92.76%.The company had revenue of $13.78 million for the quarter, compared to analyst estimates of $14.48 million.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Venus Concept in a report on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Venus Concept has a consensus rating of “Sell”.

Venus Concept Company Profile

Venus Concept Ltd. (NASDAQ: VERO) is a Canada-based medical aesthetic device company that designs, develops and commercializes minimally and noninvasive solutions for face and body rejuvenation. The company’s core product portfolio leverages proprietary technologies such as multi-polar radio frequency, pulsed electromagnetic fields and intense pulsed light to offer treatments for skin tightening, body contouring, wrinkle reduction and vascular lesion removal.

Among its flagship offerings are the Venus Legacy platform, which combines radio frequency and electromagnetic pulses for cellulite reduction and circumferential reduction, and the Venus Versa system, a multi-application device for facial revitalization, acne treatment, hair removal and photorejuvenation.